---
agency: Department of Health and Human Services
applicant_types:
- Federal
- Federally Recognized lndian Tribal Governments
- Government - General
- Local (includes State-designated lndian Tribes, excludes institutions of higher
  education and hospitals
- Other public institution/organization
- Profit organization
- Public nonprofit institution/organization (includes institutions of higher education
  and hospitals)
- Small business (less than 500 employees)
- Sponsored organization
- State
- State (includes District of Columbia, public institutions of higher education and
  hospitals)
- U.S. Territories and possessions
- U.S. Territories and possessions (includes institutions of higher education and
  hospitals)
assistance_types:
- Cooperative Agreements
beneficiary_types:
- Federally Recognized Indian Tribal Governments
- Local
- Other public institution/organization
- Private nonprofit institution/organization
- Profit organization
- Public nonprofit institution/organization
- State
- U.S. Territories
categories:
- Health - Prevention and Control
cfda: '93.080'
objective: To work with State health agencies and other public, private, and nonprofit
  organizations in planning, development, implementation, coordination, or evaluation
  of programs or other activities related to improved blood disorders.  To provide
  a national, State or local focus for the prevention of conditions in persons with
  blood disorders; to employ epidemiological methods to set priorities, build capacity
  and direct health promotion interventions for persons with blood disorders. To expand
  public health training opportunities through fellowships to introduce geneticists,
  epidemiologists, and clinicians to public health practice through education, training
  and career-enhancing experiences.
obligations: '[{"key": "SAM.gov Estimate", "year": "2019", "amount": 0.0}, {"key":
  "SAM.gov Actual", "year": "2019", "amount": 0.0}, {"key": "USASpending.gov Obligations",
  "year": "2019", "amount": 7664878.0}, {"key": "SAM.gov Estimate", "year": "2020",
  "amount": 0.0}, {"key": "SAM.gov Actual", "year": "2020", "amount": 8466345.0},
  {"key": "USASpending.gov Obligations", "year": "2020", "amount": 8557944.0}, {"key":
  "SAM.gov Estimate", "year": "2021", "amount": 8897760.0}, {"key": "SAM.gov Actual",
  "year": "2021", "amount": 11282178.0}, {"key": "USASpending.gov Obligations", "year":
  "2021", "amount": 11222427.43}, {"key": "SAM.gov Estimate", "year": "2022", "amount":
  11282178.0}, {"key": "SAM.gov Actual", "year": "2022", "amount": 9926726.0}, {"key":
  "USASpending.gov Obligations", "year": "2022", "amount": 10309096.67}, {"key": "SAM.gov
  Estimate", "year": "2023", "amount": 11282178.0}, {"key": "SAM.gov Actual", "year":
  "2023", "amount": 0.0}, {"key": "USASpending.gov Obligations", "year": "2023", "amount":
  6372521.0}]'
sub-agency: Centers for Disease Control and Prevention
title: 'Blood Disorder Program: Prevention, Surveillance, and Research '
---
